Fulltext

Cardiovascular Effects of Neuropeptide Y

Waeber, Bernard ; Aubert, Jean-François ; Corder, Roger ; Evéquoz, Dominique ; Nussberger, Jürg ; Gaillard, Rolf ; Brunner, Hans R.

In: American Journal of Hypertension, 1988, vol. 1, no. 2, p. 193-199

Ajouter à la liste personnelle
    Titre
    • Cardiovascular Effects of Neuropeptide Y
    Auteur
    • Waeber, Bernard. Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne
    • Aubert, Jean-François. Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne
    • Corder, Roger. Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne
    • Evéquoz, Dominique. Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne
    • Nussberger, Jürg. Clinique Médicale, Hôpital Cantonal Universitaire, Geneva
    • Gaillard, Rolf. Clinique Médicale, Hôpital Cantonal Universitaire, Geneva
    • Brunner, Hans R.. Division of Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • American Journal of Hypertension, 1988, vol. 1, no. 2, p. 193-199. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:302914
    Summary
    Neuropeptide Y (NPY) is present in the brain, the adrenal medulla, and peripheral sympathetic nerves. This peptide is released together with catecholamines during sympathoadrenal activation. It possesses direct vasoconstrictor properties that are not dependent on simultaneous adrenergic activation. Moreover, it potentiates the vascular effect of several stimulatory substances and may contribute to the modulation of blood pressure responsiveness under a number of circumstances. NPY may also be indirectly involved in the control of blood pressure through regulating the release of hormones with well-established actions on the cardiovascular system. Am J Hypertens 1988;1:193-199